
Learn what market capitalisation means, how ASX market cap is calculated, and the key differences between small-, mid-, and large-cap stocks when comparing Australian-listed companies.

IGO (ASX: IGO) delivers strong FY26 results with disciplined execution, expanding margins at Greenbushes and Nova, and strategic portfolio optimisation aligned with global energy transition.

AVITA Medical is strengthening its commercial position as revenue growth improves, cash burn reduces, and its regenerative medicine portfolio expands. The company’s progress in product adoption and operational efficiency keeps it positioned as a speculative healthcare growth story.
.webp&w=828&q=75)
Learn the key differences between the ASX 200 and All Ordinaries, including company coverage, investment uses, and how each index helps investors understand the Australian share market.
.webp&w=828&q=75)
Bannerman Energy (ASX: BMN) advances Etango uranium project with CNNC financing, strong early works execution, and rising uranium prices, positioning as a leveraged mid-cap growth play in a buoyant nuclear fuel market.
.webp&w=828&q=75)
Felix Gold is advancing Alaskan antimony and gold assets, with potential US$18 million DOE pilot-processing funding driving investor interest. The non-dilutive funding could support domestic antimony supply, though project execution, permitting and financing risks remain.